Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
9.48 0.01(0.05%) Jul 29, 4:00PM EDT
Prev Close:9.47
Open:9.51
Bid:8.96 x 1100
Ask:10.50 x 500
1y Target Est:7.33
Beta:0.53
Next Earnings Date:11-Aug-14PDLI Earnings announcement
Day's Range:9.41 - 9.57
52wk Range:7.38 - 10.21
Volume:1,091,887
Avg Vol (3m):2,103,810
Market Cap:1.52B
P/E (ttm):5.45
EPS (ttm):1.74
Div & Yield:0.60 (6.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIUp 0.05%1.52B
AMGN93.35B
SGEN4.33B
XOMA419.04M

Key Statistics

Forward P/E (1 yr):4.64
P/S (ttm):3.10
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.06
Quarterly EPS Est (Jun-14) :0.46
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback